{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:55:18Z","timestamp":1760151318693,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) convened virtually on 4 November 2021. The WCGCCC is an interactive multi-disciplinary conference attended by health care professionals, including surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals from across four Western Canadian provinces, British Columbia, Alberta, Saskatchewan, and Manitoba, who are involved in the care of patients with gastrointestinal cancer. They participated in presentation and discussion sessions for the purpose of developing recommendations on the role of systemic therapy and its optimal sequence in patients with resectable metastatic colorectal cancer.<\/jats:p>","DOI":"10.3390\/curroncol29030147","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T12:35:37Z","timestamp":1646742937000},"page":"1796-1807","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-698X","authenticated-orcid":false,"given":"Shahid","family":"Ahmed","sequence":"first","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, 20 Campus Drive, University of Saskatchewan, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Bosma","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Moser","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahida","family":"Ahmed","sequence":"additional","affiliation":[{"name":"CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Brunet","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, 20 Campus Drive, University of Saskatchewan, Saskatoon, SK S7N 4H4, Canada"},{"name":"Department of Radiation Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Davies","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Doll","sequence":"additional","affiliation":[{"name":"Arnie Charbonneau Cancer Institute, Alberta Health Service, Calgary, AB T2N 4Z6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorie-Anna","family":"Dueck","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, 20 Campus Drive, University of Saskatchewan, Saskatoon, SK S7N 4H4, Canada"},{"name":"Department of Medical Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-2583","authenticated-orcid":false,"given":"Christina A.","family":"Kim","sequence":"additional","affiliation":[{"name":"CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-5111","authenticated-orcid":false,"given":"Shuying","family":"Ji","sequence":"additional","affiliation":[{"name":"Shared Health, Winnipeg, MB R3B 2K6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-5399","authenticated-orcid":false,"given":"Duc","family":"Le","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, 20 Campus Drive, University of Saskatchewan, Saskatoon, SK S7N 4H4, Canada"},{"name":"Department of Radiation Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0913-6046","authenticated-orcid":false,"given":"Richard","family":"Lee-Ying","sequence":"additional","affiliation":[{"name":"Arnie Charbonneau Cancer Institute, Alberta Health Service, Calgary, AB T2N 4Z6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Lim","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"McGhie","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency, Victoria, BC V8R 6V5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Mulder","sequence":"additional","affiliation":[{"name":"Cross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Manitoba, Winnipeg, MB R3T 2N2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Ravi","sequence":"additional","affiliation":[{"name":"Saskatchewan Health Authority, Saskatoon, SK S7K 0M7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Renouf","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Schellenberg","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency, Surrey, BC V3V 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph P. W.","family":"Wong","sequence":"additional","affiliation":[{"name":"CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, 20 Campus Drive, University of Saskatchewan, Saskatoon, SK S7N 4H4, Canada"},{"name":"Department of Medical Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wiederkehr, J., Wiederkehr, B., and Wiederkehr, H. (2019). Colorectal liver metastases. Surgical Challenges in the Management of Liver Disease, BoD\u2013Books on Demand.","DOI":"10.5772\/intechopen.80558"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection\/Ablation for Colorectal Liver Metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/bjs.7032","article-title":"Surgical management and outcomes of colorectal cancer liver metastases","volume":"97","author":"Morris","year":"2010","journal-title":"Br. J. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients","volume":"250","author":"Pulitano","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","article-title":"Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Fran\u00e7aise de Chirurgie","volume":"77","author":"Nordlinger","year":"1996","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.surg.2021.06.033","article-title":"The evolution of surgery for colorectal liver metastases: A persistent challenge to improve survival","volume":"170","author":"Kambakamba","year":"2021","journal-title":"Surgery"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s11605-018-3748-3","article-title":"The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases","volume":"22","author":"Wang","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0003134820951451","article-title":"The Future Liver Remnant: Definition, Evaluation, and Management","volume":"87","author":"Dixon","year":"2021","journal-title":"Am. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/bjs.5581","article-title":"Current role of radiofrequency ablation for the treatment of colorectal liver metastases","volume":"93","author":"McKay","year":"2006","journal-title":"Br. J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1477-2574.2012.00607.x","article-title":"A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases","volume":"15","author":"Lam","year":"2013","journal-title":"HPB"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5306\/wjco.v6.i5.142","article-title":"Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned","volume":"6","author":"Simoneau","year":"2015","journal-title":"World J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jso.25430","article-title":"Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy","volume":"119","author":"Kawaguchi","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5009\/gnl19233","article-title":"Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: What Have We Learned?","volume":"14","author":"Lang","year":"2020","journal-title":"Gut Liver"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1200\/JCO.2005.03.2334","article-title":"Neoadjuvant Chemotherapy for Metastatic Colon Cancer: A Cautionary Note","volume":"23","author":"Bilchik","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Audard","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: Correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1245\/s10434-015-4533-0","article-title":"Nodular Regenerative Hyperplasia in Patients Undergoing Liver Resection for Colorectal Metastases After Chemotherapy: Risk Factors, Preoperative Assessment and Clinical Impact","volume":"22","author":"Majno","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/hep.25935","article-title":"Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: A case-control study","volume":"56","author":"Reddy","year":"2012","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/bjs.7194","article-title":"Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection","volume":"97","author":"Kalish","year":"2010","journal-title":"Br. J. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"82473","DOI":"10.18632\/oncotarget.12666","article-title":"Bevacizumab and wound-healing complications: A systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Volk, A.M., Fritzmann, J., Reissfelder, C., Weber, G.F., Weitz, J., and Rahbari, N.N. (2016). Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2095-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/SLA.0000000000004331","article-title":"Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?","volume":"272","author":"Ignatavicius","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1470-2045(09)70064-6","article-title":"Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases","volume":"10","author":"Chun","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/sj.bjc.6603670","article-title":"Safe liver resection following chemotherapy for colorectal metastases is a matter of timing","volume":"96","author":"Welsh","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ags3.12276","article-title":"How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective","volume":"3","author":"Imai","year":"2019","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(07)61866-2","article-title":"Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study","volume":"370","author":"Barnwell","year":"2007","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial","volume":"27","author":"Boni","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/annonc\/mdp236","article-title":"A randomized phase III study comparing adjuvant 5-fluorouracil\/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer","volume":"20","author":"Ychou","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1200\/JCO.21.01032","article-title":"Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial","volume":"39","author":"Kanemitsu","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","article-title":"Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials","volume":"26","author":"Mitry","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","article-title":"Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial","volume":"24","author":"Portier","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1245\/s10434-014-4354-6","article-title":"Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis","volume":"22","author":"Araujo","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3748\/wjg.v22.i2.519","article-title":"Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis","volume":"22","author":"Brandi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1245\/s10434-009-0781-1","article-title":"Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases","volume":"17","author":"Chua","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_43","first-page":"1849","article-title":"Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: A systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Tagliaferri","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.hpb.2016.03.001","article-title":"Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases","volume":"18","author":"Khoo","year":"2016","journal-title":"HPB"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"37277","DOI":"10.18632\/oncotarget.8671","article-title":"The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: A systematic review and meta-analysis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e000343","DOI":"10.1136\/esmoopen-2018-000343","article-title":"Postoperative chemotherapy with single-agent fluoropyrimidines after resection of colorectal cancer liver metastases: A meta-analysis of randomised trials","volume":"3","author":"Mauri","year":"2018","journal-title":"ESMO Open"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ejso.2015.05.020","article-title":"Peri-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis","volume":"41","author":"Wang","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/1471-2407-10-309","article-title":"Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials","volume":"10","author":"Wieser","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fphar.2019.01052","article-title":"Comparative Efficacy of Preoperative, Postoperative, and Perioperative Treatments for Resectable Colorectal Liver Metastases: A Network Meta-Analysis","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_50","first-page":"672","article-title":"Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): Results of the ENG (EORTC\/NCIC CTG\/GIVIO) randomized trial","volume":"35","author":"Langer","year":"2002","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/MD.0000000000000379","article-title":"Systematic review with network meta-analysis: Adjuvant chemotherapy for resected colorectal liver metastases","volume":"94","author":"Zhu","year":"2015","journal-title":"Medicine"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Hasegawa, K., Saiura, A., Takayama, T., Miyagawa, S., Yamamoto, J., Ijichi, M., Teruya, M., Yoshimi, F., Kawasaki, S., and Koyama, H. (2016). Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162400"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.ejso.2021.07.024","article-title":"Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis","volume":"47","author":"Bosma","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1200\/JOP.2015.009407","article-title":"Surgical Management of Liver Metastases From Colorectal Cancer","volume":"12","author":"Dhir","year":"2016","journal-title":"J. Oncol. Pr."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ayez, N., Van Der Stok, E.P., De Wilt, H., Radema, S.A., Van Hillegersberg, R., Roumen, R.M., Vreugdenhil, G., Tanis, P.J., Punt, C.J., and Dejong, C.H. (2015). Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: The CHARISMA randomized multicenter clinical trial. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1199-8"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1245\/s10434-009-0492-7","article-title":"The Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases","volume":"16","author":"Benoist","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: The New EPOC randomised controlled trial","volume":"15","author":"Primrose","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.6004\/jnccn.2018.0021","article-title":"NCCN Guidelines Insights: Colon Cancer, Version 2.2018","volume":"16","author":"Benson","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1200\/JCO.21.01972","article-title":"Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?","volume":"39","author":"Booth","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/3\/147\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:33:37Z","timestamp":1760135617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/3\/147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["curroncol29030147"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29030147","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}